Published in Blood on August 01, 1980
Embryonic----Fetal Hb switch in humans: studies on erythroid bursts generated by embryonic progenitors from yolk sac and liver. Proc Natl Acad Sci U S A (1984) 1.24
Molecular comparison of delta beta-thalassemia and hereditary persistence of fetal hemoglobin DNAs: evidence of a regulatory area? Proc Natl Acad Sci U S A (1982) 1.02
Determination of the hemoglobin F program in human progenitor-derived erythroid cells. J Clin Invest (1985) 0.77
Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ (2007) 8.08
Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med (1998) 7.07
Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A (1995) 5.15
High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. Cancer Res (1998) 3.56
Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol (1994) 3.19
Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ (2006) 3.12
Infectious viral DNA of murine leukemia virus. Proc Natl Acad Sci U S A (1975) 3.09
Murine leukemia virus: detection of unintegrated double-stranded DNA forms of the provirus. Proc Natl Acad Sci U S A (1975) 3.07
The severe form of alpha thalassaemia is caused by a haemoglobin gene deletion. Nature (1974) 3.04
The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell (1993) 2.96
Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1. Nature (1999) 2.88
Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group. Ann Oncol (2007) 2.85
Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells. J Natl Cancer Inst (1998) 2.75
Sox2 regulatory sequences direct expression of a (beta)-geo transgene to telencephalic neural stem cells and precursors of the mouse embryo, revealing regionalization of gene expression in CNS stem cells. Development (2000) 2.73
Differential and stage-related expression in embryonic tissues of a new human homoeobox gene. Nature (1987) 2.42
Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit hearts subjected to ischemia and reflow. J Biol Chem (1993) 2.38
The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiation. Proc Natl Acad Sci U S A (2007) 2.34
Survival and complications in thalassemia. Ann N Y Acad Sci (2005) 2.25
Neuro-glial differentiation of human bone marrow stem cells in vitro. Exp Neurol (2005) 2.17
Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer. Blood (1996) 2.17
KDR receptor: a key marker defining hematopoietic stem cells. Science (1999) 2.13
Delta-beta-thalassemia is due to a gene deletion. Cell (1976) 2.12
Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. N Engl J Med (1991) 2.06
Aplastic crisis due to parvovirus infection in pyruvate kinase deficiency. Lancet (1983) 2.05
Diastolic perfusion time at ischemic threshold in patients with stress-induced ischemia. Circulation (1991) 1.97
Pharmacological strategies for overcoming multidrug resistance. Curr Drug Targets (2006) 1.96
Partially single-stranded form of free Moloney viral DNA. Nature (1975) 1.93
Globin gene deletion in HPFH, delta (o) beta (o) thalassaemia and Hb Lepore disease. Nature (1979) 1.88
Haemoglobin switching in human embryos: asynchrony of zeta----alpha and epsilon----gamma-globin switches in primitive and definite erythropoietic lineage. Nature (1985) 1.87
Local effect of serotonin released during coronary angioplasty. N Engl J Med (1994) 1.81
High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda. Hepatology (1998) 1.79
Expression of caveolin-1 is required for the transport of caveolin-2 to the plasma membrane. Retention of caveolin-2 at the level of the golgi complex. J Biol Chem (1999) 1.79
An erythroid specific enhancer upstream to the gene encoding the cell-type specific transcription factor GATA-1. Nucleic Acids Res (1991) 1.76
Splenectomy and thrombosis: the case of thalassemia intermedia. J Thromb Haemost (2010) 1.71
HOX4 genes encode transcription factors with potential auto- and cross-regulatory capacities. EMBO J (1991) 1.70
Molecular mechanisms of human hemoglobin switching: selective undermethylation and expression of globin genes in embryonic, fetal, and adult erythroblasts. Proc Natl Acad Sci U S A (1983) 1.68
Age-related effects on atherogenesis and scavenger enzymes of intracranial and extracranial arteries in men without classic risk factors for atherosclerosis. Stroke (2001) 1.66
Erythropoietin alone induces erythroid burst formation by human embryonic but not adult BFU-E in unicellular serum-free culture. Blood (1989) 1.64
Segmental duplications involving the alpha-globin gene cluster are causing beta-thalassemia intermedia phenotypes in beta-thalassemia heterozygous patients. Blood Cells Mol Dis (2008) 1.63
Effect of glycaemic control and age on low-density lipoprotein susceptibility to oxidation in diabetes mellitus type 1. Eur Heart J (2001) 1.62
Survival and disease complications in thalassemia major. Ann N Y Acad Sci (1998) 1.62
The NS2 protein of hepatitis C virus is a transmembrane polypeptide. J Virol (1995) 1.61
Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha. J Immunol (1992) 1.59
The deletion in a type of delta 0-beta 0-thalassaemia begins in an inverted AluI repeat. Nature (1982) 1.56
cDNA cloning and functional characterization of the mouse Ca2+-gated K+ channel, mIK1. Roles in regulatory volume decrease and erythroid differentiation. J Biol Chem (1998) 1.56
New-onset angina preceding acute myocardial infarction is associated with improved contractile recovery after thrombolysis. Eur Heart J (1998) 1.54
A protein factor binding to an octamer motif in the gamma-globin promoter disappears upon induction of differentiation and hemoglobin synthesis in K562 cells. Nucleic Acids Res (1987) 1.54
Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis. Blood (1999) 1.54
Renaturation of calf thymus satellite DNA. J Mol Biol (1966) 1.54
Structural alterations of the NF-kappa B transcription factor lyt-10 in lymphoid malignancies. Oncogene (1993) 1.51
Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation. Leukemia (2006) 1.51
Accentuated response to phenylhydrazine and erythropoietin in mice genetically impaired for their GATA-1 expression (GATA-1(low) mice). Blood (2001) 1.51
Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association. Hepatology (1992) 1.49
The effects of HPFH mutations in the human gamma-globin promoter on binding of ubiquitous and erythroid specific nuclear factors. Nucleic Acids Res (1988) 1.49
Presence of gene for beta globin in homozygous beta0 thalassaemia. Nature (1976) 1.48
Proviral DNA of Moloney leukemia virus: purification and visualization. Science (1976) 1.47
HOXB7: a key factor for tumor-associated angiogenic switch. Cancer Res (2001) 1.47
Palmitylation of viral membrane glycoproteins takes place after exit from the endoplasmic reticulum. J Biol Chem (1989) 1.45
An erythroid specific nuclear factor binding to the proximal CACCC box of the beta-globin gene promoter. Nucleic Acids Res (1988) 1.45
Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer. Br J Cancer (1995) 1.44
A molecular study of a family with Greek hereditary persistence of fetal hemoglobin and beta-thalassemia. EMBO J (1984) 1.44
Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring. J Inherit Metab Dis (2008) 1.41
Renaturation properties and localization in heterochromatin of human satellite DNA's. Biochim Biophys Acta (1971) 1.39
An analysis of which subgroups of multiple myeloma patients, divided according to b(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapy. Haematologica (1999) 1.39
Human embryonic hemopoiesis. Kinetics of progenitors and precursors underlying the yolk sac----liver transition. J Clin Invest (1986) 1.39
Comparative analysis of hematopoietic growth factors released by stromal cells from normal donors or transplanted patients. Blood (1990) 1.38
Selection of lineage-restricted cell lines immortalized at different stages of hematopoietic differentiation from the murine cell line 32D. J Cell Biol (1989) 1.37
Measurement of two- and three-nucleon short-range correlation probabilities in nuclei. Phys Rev Lett (2006) 1.37
Unrelated placental blood for bone marrow reconstitution: organization of the placental blood program. Blood Cells (1994) 1.35
HOXB7 constitutively activates basic fibroblast growth factor in melanomas. Mol Cell Biol (1996) 1.35
'Advanced' generation lentiviruses as efficient vectors for cardiomyocyte gene transduction in vitro and in vivo. Gene Ther (2003) 1.35
Role of signal recognition particle in the membrane assembly of Sindbis viral glycoproteins. Eur J Biochem (1984) 1.34